Anti-Human H1 Complex Recombinant Antibody
-
产品编号
YR1082
-
别名
科研级 Derlotuximab ( 地洛妥单抗, 地洛昔单抗 ), Anti-H1 Complex Recombinant Antibody, Research Grade Derlotuximab
-
规格
- 1mg
- 5mg
Alias | 科研级 Derlotuximab ( 地洛妥单抗, 地洛昔单抗 ), Anti-H1 Complex Recombinant Antibody, Research Grade Derlotuximab |
Catalog Number | YR1082 |
Molecular Name | Derlotuximab |
CAS Number | 340013-96-9 |
Target | H1 complex[Homo sapiens] |
Antibody Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Formulation | PBS, pH7.5 |
Shipping Condition | Shipped on ice packs. |
Background | Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. |
Remarks | This product is for research use only. |